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Abstract
Introduction: The cause of chest pain in patients presenting to the emergency room often remains
unclear. We present a case of essential thrombocythemia as a novel cause of atypical chest pain,
which responded dramatically to a simple treatment intervention.
Case presentation: A 54-year-old patient presenting with atypical chest pain was found to have
essential thrombocythemia as a cause for her chest pain. She responded dramatically to aspirin
therapy and had no recurrence of symptoms over 3 months.
Conclusion: Essential thrombocythemia should be considered as a differential cause in patient
presenting with atypical chest pain, vasomotor symptoms and high platelet counts. These symptoms
are generally more bothersome than dangerous and are usually controlled by low dose aspirin
therapy.
Introduction
Acute chest pain (CP) is one of the most common reasons
for ER visits and its management involves establishing the
cause while excluding potentially life-threatening condi-
tions. It, therefore, poses a significant diagnostic challenge.
Despite extensive work up to determine the cause of chest
pain, the diagnosis often remains unclear leaving both the
patient and the physician unsatisfied. We present a case of
atypical chest pain due to a relatively unremarkable cause;
Essential thrombocythemia (ET), which responded dra-
matically to a simple treatment intervention.
Case presentation
A 54-year-old Caucasian female presented to ER with
episodes of CP for the last 4 hours. The pain was
characterised as acute onset, sharp, non-exertional, non-
radiating pain localised to left side of the chest. It was 10/
10 in severity with no discernable aggravating or relieving
factors with each episode lasting for 2–3 minutes. Certain
sensory symptoms had preceded the onset of CP. This
comprised of sudden onset numbness of the left thumb
followed by a tingling sensation in the shoulders with
radiation distally into both hands. Subsequently, patient
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(page number not for citation purposes)also developed severe, generalized, headache along with
lights flashing across her eyes. By the time she reached the
ER, her symptoms had completely resolved. Her past
medical history was significant only for the diagnosis of
essential thrombocythemia (ET) based on a bone marrow
biopsy and a positive JAK2 mutation test. She had not
required any previous treatment for this condition. Her
baseline platelet count had ranged between 600 x 10
9/l to
750 x 10
9/l over the last one year. Initial laboratory
investigations in the ER revealed normal basic metabolic
panel and complete blood count except for a platelet
count of 935 x 10
9/l. Her chest pain was evaluated with
three sets of cardiac enzymes and exercise stress echocar-
diogram which were all normal. Her chest X-ray did not
reveal any infiltrates or pneumothorax. CT scan of chest
with contrast showed no evidence of pulmonary embo-
lism or aortic dissection. Her EKG revealed normal sinus
rhythm. Her 24 hour continuous telemetry also did not
show any arrhythmias. Her atypical, non-localizing,
sensory symptoms with negative cardiopulmonary work
up were subsequently attributed to vasomotor manifesta-
tions due to ET. The patient was reassured and started on a
low dose aspirin therapy. At 12 weeks follow up, she
reported no subsequent similar episodes.
Discussion
Essential thrombocythemia (ET) is a clonal stem cell
disorder characterized by a persistent, nonreactive throm-
bocythemic state that is not accounted for by any of the
other chronic myeloproliferative disorders [1].
Our patient presented with classic vasomotor manifesta-
tions of ET, which may be present in approximately half of
the patients with this myeloproliferative disorder. The
common vasomotor symptoms experienced by these
patients include headache, palpitations, atypical chest
pain, distal paresthesias [2] or transient visual distur-
bances such as amaurosis fugax, scintillating scotomata
and ophthalmic migraine [3]. Platelet-mediated ischemic
and thrombotic processes in the end-arterial microvascu-
lature are the likely cause for this symptoms [3]. The
diagnosis of ET in our patient had been previously
confirmed by appropriate tests. The vasomotor symptoms
associated with ET are generally more distressing than
dangerous, and are usually controlled by treatment with
low dose of acetylsalicylic acid (ASA) [4]. Since our patient
responded adequately to aspirin therapy, there was no
need for cytoreductive intervention.
Conclusion
Whereas the work up of acute chest pain to rule out
potentially life threatening conditions is essential, the
recognition and appropriate treatment of relatively unre-
markable causes of chest pain like ET can relieve the
patients’ symptoms and may also reduce the excessive
utilization of health care resources.
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